As of December 31, 2011 Primatene Mist inhaler products are no longer available, states the Food and Drug Administration. Primatene is a bronchodilator, which begins relieving clogged breathing passages and bronchial asthma as quickly as 15 seconds after use, explains Primatene. Primatene Mist features a plastic-coated glass canister to protect the medication's light-sensitive contents. A vial of Primatene Mist provides 270 puffs, and the medication is free of gelatin, lead, gluten and lactose.
Primatene Mist products do not contain steroids or sulfites, reports the company's website. The medication is useful for relieving bronchial asthma symptoms, such as wheezing, tightness of chest, or shortness of breath.
Due to the use of chloroflourocarbons, or CFCs, Primatene Mist was banned by the FDA effective December 31, 2011, states the agency. The United States signed an agreement along with many other countries to phase out ozone-depleting CFCs.
Primatene remains available in tablet form as an over-the-counter asthma medication, reports About. In 2014, Primatene submitted a new mist for FDA approval which features hydroflouroalkane in lieu of CFCs. The FDA rejected this proposal due to the absence of a dose counter and the frequency at which the inhaler clogged. Inhaled epinephrine is not usually recommended to relieve acute asthma symptoms, which is another reason the FDA rejected this proposal.